(Total Views: 528)
Posted On: 02/21/2021 7:44:43 AM
Post# of 72444
https://www.nytimes.com/2021/02/19/opinion/co...e=Homepage
For those of you fascinated by the epidemiology and origins of contagions, I recommend this NYTimes Opinion piece written by David Quammen. Quammen is an excellent writer/scientist. I first read his work a decade ago when he published Spillover. I strongly recommend this book. In fact, I’ve been recommending it to friends and family since I first read it and have done so dozens of times during the current pandemic. I am sure many in this community have read it. If you have you may agree with me that Spillover and Quammen’s other books represent a chicken or egg model. As in; Read it, becomes a biotech investor or became a biotech investor, read it. It an essential text for those who wish to know why.
On an Innovation Pharmaceuticals note; for those who might argue the COVID-19 opportunity is past (it isn’t), and IPIX has missed the bus (it hasn’t), there will be other buses. Brilacidin has pan-Corona potential. Modeled after nature’s Host Defense Proteins (HDPs), Brilacidin, destroys virus (and bacteria, and fungal pathogens), by rupturing their cell membrane. Brilacidin will play a vital role as humanities first line of defense, first-in-class cure for existing and novel (emerging), illnesses for decades to come, in the form of multiple indications. Know what you own. Know it potential value.
For those of you fascinated by the epidemiology and origins of contagions, I recommend this NYTimes Opinion piece written by David Quammen. Quammen is an excellent writer/scientist. I first read his work a decade ago when he published Spillover. I strongly recommend this book. In fact, I’ve been recommending it to friends and family since I first read it and have done so dozens of times during the current pandemic. I am sure many in this community have read it. If you have you may agree with me that Spillover and Quammen’s other books represent a chicken or egg model. As in; Read it, becomes a biotech investor or became a biotech investor, read it. It an essential text for those who wish to know why.
On an Innovation Pharmaceuticals note; for those who might argue the COVID-19 opportunity is past (it isn’t), and IPIX has missed the bus (it hasn’t), there will be other buses. Brilacidin has pan-Corona potential. Modeled after nature’s Host Defense Proteins (HDPs), Brilacidin, destroys virus (and bacteria, and fungal pathogens), by rupturing their cell membrane. Brilacidin will play a vital role as humanities first line of defense, first-in-class cure for existing and novel (emerging), illnesses for decades to come, in the form of multiple indications. Know what you own. Know it potential value.
(3)
(0)Scroll down for more posts ▼
